(a) Senolytics—improve adiponectin profile, attenuate renal fibrosis, and augment renal cortical oxygenation(b) RAS inhibitors—lower visceral fat and WAT leptin secretion(c) SGLT2 inhibitors—prevent glomerular hyperfiltration and hinder renal damage progression. The gene discussed is LEP; the disease is renal fibrosis.